Lower serum IL-10 Is an independent predictor of IBS among volunteers in Mexico

American Journal of Gastroenterology

Volumn 107, Issue 5, 2012, Pages 747-753

  Schmulson, Max ^a   Pulido London, Daniela ^a   Rodriguez, Oscar ^a   Morales Rochlin, Norma ^a   Martinez García, Rosalinda ^a   Gutierrez Ruiz, Ma Concepción ^b   López Alvarenga, Juan Carlos ^c   Robles Díaz, Guillermo ^a   Gutiérrez Reyes, Gabriela ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PLASMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEFECATION HABIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER AND SEX; HUMAN; IMMUNOREGULATION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEXICO; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL MODEL; UNIVERSITY STUDENT; VOLUNTEER; BLOOD;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; IRRITABLE BOWEL SYNDROME; MALE; MEXICO; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862339009     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.484     Document Type: Article

References (40)

1. Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005;21:663-76. (Pubitemid 40468994)
2. Rodriguez-Fandino O, Hernandez-Ruiz J, Schmulson M. From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil 2010;16:363-73.
3. Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 2005;34:235-45, vi-vii. (Pubitemid 40615953)
4. Gwee KA. Post-infectious irritable bowel syndrome, an inflammation-immunological model with relevance for other IBS and functional dyspepsia. J Neurogastroenterol Motil 2010;16:30-4.
5. Kassinen A, Krogius-Kurikka L, Makivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007;133:24-33. (Pubitemid 47031125)
6. Brint EK, MacSharry J, Fanning A et al. Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol 2011;106:329-36.
7. Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009;20:43-59.
8. Ortiz-Lucas M, Saz-Peiro P, Sebastian-Domingo JJ. Irritable bowel syndrome immune hypothesis. Part two: the role of cytokines. Rev Esp Enferm Dig 2010;102:711-7.
9. Macsharry J, O'Mahony L, Fanning A et al. Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol 2008;43:1467-76.
10. Camilleri M. Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci 2009;54:2318-24.
11. Villani AC, Lemire M, Thabane M et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010;138:1502-13.
12. Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther 2010;32:738-55.
13. Schmulson M, Adeyemo M, Gutierrez-Reyes G et al. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-32.
14. Dinan TG, Quigley EM, Ahmed SM et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006;130:304-11. (Pubitemid 43202030)
15. Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913-20. (Pubitemid 46440872)
16. Schmulson M, Ortiz O, Santiago-Lomeli M et al. Frequency of functional bowel disorders among healthy volunteers in Mexico City. Dig Dis 2006;24:342-7. (Pubitemid 44114427)
17. Kindt S, Van Oudenhove L, Broekaert D et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009;21:389-98.
18. Scully P, McKernan DP, Keohane J et al. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010;105:2235-43.
19. Maynard CL, Weaver CT. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev 2008;226:219-33.
20. Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol Suppl 1999;57:16-21. (Pubitemid 29210245)
21. Glocker E, Grimbacher B. Inflammatory bowel disease: is it a primary immunodeficiency? Cell Mol Life Sci 2012;69:41-8.
22. Gasche C, Bakos S, Dejaco C et al. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol 2000;20:362-70.
23. Chang L, Adeyemo M, Karagiannidis I et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol; advance online publication, 13 December 2011; doi:10.1038/ajg.2011.423 [e-pub ahead of print].
24. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51. (Pubitemid 40585355)
25. Pitychoutis PM, Papadopoulou-Daifoti Z. Of depression and immunity: does sex matter? Int J Neuropsychopharmacol 2010;13:675-89.
26. De Leon-Nava MA, Nava K, Soldevila G et al. Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. J Steroid Biochem Mol Biol 2009;113:57-64.
27. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997;158:446-51. (Pubitemid 127483887)
28. Giron-Gonzalez JA, Moral FJ, Elvira J et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000;143:31-6. (Pubitemid 30482197)
29. Temple SE, Pham K, Glendenning P et al. Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: correlation with elevated expression of TLR4. Cell Immunol 2008;251:69-71.
30. Moxley G, Stern AG, Carlson P et al. Premenopausal sexual dimorphism in lipopolysaccharide-stimulated production and secretion of tumor necrosis factor. J Rheumatol 2004;31:686-94. (Pubitemid 38451253)
31. Gecse K, Roka R, Ferrier L et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008;57:591-9.
32. Marshall JK, Thabane M, Garg AX et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 2004;20:1317-22. (Pubitemid 40040078)
33. Dunlop SP, Hebden J, Campbell E et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006;101:1288-94. (Pubitemid 43829995)
34. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009;41:850-3.
35. Karalis KP, Giannogonas P, Kodela E et al. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009;276:5747-54.
36. Borecki IB, Higgins M, Schreiner PJ et al. Evidence for multiple determinants of the body mass index: the National Heart, Lung, and Blood Institute Family Heart Study. Obes Res 1998;6:107-14. (Pubitemid 128679650)
37. Ortiz OM R-TJ, Valdovinos MA, Vargas-Voráckova F, Schmulson M. Frecuencia de factores desencadenantes extero e interoceptivos en la presentación inicial del síndrome de intestino irritable (SII) en un hospital de tercer nivel en México: Baja frecuencia de de SII postinfeccioso? Rev Gastroenterol Méx 2003;68 (Suppl 2):98-9.
38. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010;34:J258-65.
39. Achur RN, Freeman WM, Vrana KE. Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J Neuroimmune Pharmacol 2010;5:83-91.
40. Maes M, Van Bockstaele DR, Gastel A et al. The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation. Neuropsychobiology 1999;39:1-9. (Pubitemid 29037758)